GlassScriptPhysician profile
Samuel Rice
NPI 1598044661
$6,611.77
in general payments reported to CMS, 2019-2025
9 companies · $499 in 2025
The $499 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.66 · 2020: $128 · 2021: $684 · 2022: $1,016 · 2023: $488 · 2024: $3,755 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,711 · Travel and Lodging: $2,032.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,710.65 |
| Travel and Lodging | $2,032.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,778.15 | 2019-2025 | Obsidio, Embold Fibered, Therasphere Y90 Glass Microspheres 10 Gbq |
| Penumbra, INC. | $579.87 | 2022-2024 | Penumbra System, Indigo System |
| Inari Medical, INC. | $452.41 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sirtex Medical INC | $409.87 | 2021-2023 | Sir-Spheres Microspheres |
| Balt USA, LLC | $218.14 | 2022-2024 | Prestige Coil System |
| Terumo Medical Corporation | $104.29 | 2020 | |
| Stryker Corporation | $45.73 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Varian Medical Systems, INC. | $23.31 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.